Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment

Several studies have linked circulating cell-free mitochondrial DNA (ccf-mtDNA) to human disease. In particular, reduced ccf-mtDNA levels in the cerebrospinal fluid (CSF) of both Alzheimer’s and Parkinson’s disease (PD) patients have raised the hypothesis that ccf-mtDNA could be used as a biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowes, Hannah, Pyle, Angela, Santibanez-Koref, Mauro, Hudson, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029508/
https://www.ncbi.nlm.nih.gov/pubmed/32070373
http://dx.doi.org/10.1186/s13024-020-00362-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029508/
https://www.ncbi.nlm.nih.gov/pubmed/32070373
http://dx.doi.org/10.1186/s13024-020-00362-y

Ejemplares similares